Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

The iShares Biotechnology Indexhas fallen 2.46% in the last month of trading, and biotech stalwarts Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD ) are both down over 8%. What’s most surprising is that Celgene and Gilead are expected to have strong years in terms of earnings and the development of their respective clinical pipelines. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 0.53% in last session and … Continue reading Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

Mark DeFrance03/1803/21

Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for office purposes. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was 3.53% … Continue reading Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Jason Knox03/1103/11

Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Colin Pettis03/0403/04

Watch List: American International Group, Inc. (NYSE:AIG), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Talisman Energy Inc. (NYSE:TLM), China Yuchai International Limited (NYSE:CYD), KeyCorp. (NYSE:KEY)

Maurice “Hank” Greenberg’s argument that the U.S. sought to evade a shareholder vote on its 2008 bailout of American International Group, Inc. (NYSE:AIG) may get a boost from a Fed legal adviser’s own words. American International Group, Inc. (NYSE:AIG) belongs to Financial sector. Its net profit margin is 12.70% and weekly performance is 1.47%. On last trading day company shares ended up $54.68. American International … Continue reading Watch List: American International Group, Inc. (NYSE:AIG), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Talisman Energy Inc. (NYSE:TLM), China Yuchai International Limited (NYSE:CYD), KeyCorp. (NYSE:KEY)

Jason Knox11/2611/26

5 Stocks Under Wall Street’s Radar: Hewlett-Packard Company (NYSE:HPQ), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Banco Santander, S.A. (NYSE:SAN), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), PKG

Jefferies Group initiated coverage on shares of Hewlett-Packard Company (NYSE:HPQ) in a research report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a hold rating and a $38.00 price objective on the stock. Hewlett-Packard Company (NYSE:HPQ) belongs to Technology sector. Its net profit margin is 4.50% and weekly performance is 1.39%. On last trading day company shares ended up $36.38. Hewlett-Packard Company (NYSE:HPQ) distance from … Continue reading 5 Stocks Under Wall Street’s Radar: Hewlett-Packard Company (NYSE:HPQ), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Banco Santander, S.A. (NYSE:SAN), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), PKG

Chris Lewis11/1011/10

NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases, announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania (Penn); Inovio Pharmaceuticals; and MedImmune, the global biologics … Continue reading NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Kristen Barton10/2210/22